Parravicini C, Lecca D, Marangon D, Coppolino GT, et al. Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis. PLoS One 2020;15:e0231483.
PMID: 32320409